On This Page:
- What Is the Five-Year Survival Rate for Pancreatic Cancer?
- What Is the Pancreatic Cancer Survival Rate by Stage?
- What Is the Survival Rate After Surgery?
- What Can Patients Do to Improve Their Chances?
- Survivor Stories
- How Is the Survival Rate Determined?
- Why Is Early Detection Important?
Every pancreatic cancer patient’s case is unique, and it’s not possible to predict each person’s outcome. However, population-wide studies are done to estimate the likelihood that a person diagnosed with different types of cancer, like pancreatic cancer, will survive five years.
The American Cancer Society includes five-year relative survival rates in their Cancer Facts & Figures reports each year. This information is generated from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program.
A patient’s outcome can be affected by their:
- Disease stage
- Overall health
- Access to treatment, pancreatic cancer specialists, clinical trials and supportive care
What Is the Five-Year Survival Rate for Pancreatic Cancer?
The currently reported five-year survival rate for pancreatic cancer is 13%.1
What Is the Outlook for Pancreatic Cancer?
Over the past decade, the five-year survival rate for pancreatic cancer patients increased from 7% to 13%.2 There is an urgent need to improve survival even more. But this increase shows that progress is being made. Those percentage points mean that 13 people out of 100, instead of six people out of 100, will be alive five years after their pancreatic cancer diagnosis.
The Pancreatic Cancer Action Network is working toward better treatment options for pancreatic cancer patients and ways to find the disease earlier. We are determined to improve patient outcomes today and into the future. Contact PanCAN Patient Services for resources, support and information.
What Is the Pancreatic Cancer Survival Rate by Stage?
Localized Disease (Pancreas) Survival Rate
When the tumor is only in the pancreas, the five-year survival rate is 44%.1
Regional Disease (Lymph Nodes) Survival Rate
When pancreatic cancer has spread to nearby lymph nodes outside the pancreas, the five-year survival rate is 16%.1
Distant (Stage IV or Metastatic) Survival Rate
The five-year survival rate for distant (stage IV) pancreatic cancer is 3%.1 Distant disease has spread to other organs outside the pancreas, usually the liver or lung.
It is important for all pancreatic cancer patients, including those with stage IV cancer, to consider options outside of standard treatment.
It is also important to remember that these statistics are based on historical data, and there have been advancements in the treatment options available today.
Learn more about stage IV pancreatic cancer, including treatment options.
What Is the Survival Rate After Surgery?
Diagnosing pancreatic cancer in time for surgery can increase a patient’s survival by more than ten-fold.
In fact, a study published in 2020 demonstrated that patients whose tumor is diagnosed at the earliest stage, stage IA, can have a five-year survival of over 80%.3
What Can Patients Do to Improve Their Chances?
Pancreatic cancer patients who participate in clinical research have better outcomes. Seeing pancreatic cancer specialists, including healthcare professionals who focus on symptom management and supportive (palliative) care also improves outcomes. And, patients who receive treatment based on their biology can live longer.
For all stages, the Pancreatic Cancer Action Network strongly recommends:
- Clinical trials at diagnosis and during every treatment decision
- Genetic testing for inherited mutations as soon as possible after diagnosis and biomarker testing of tumor tissue to help determine the best treatment options
- Getting an opinion from a specialist, a physician who diagnoses and treats a high volume of pancreatic cancer patients
- Symptom management and supportive care, provided early in your diagnosis as well as during and after treatment
Contact PanCAN Patient Services to learn more about these options.
Read stories about survivors sharing personal experiences, information and hope.
PanCAN Patient Services can also connect patients and their loved ones with others one-on-one through the Survivor & Caregiver Network.
How Is the Survival Rate Determined?
For the five-year survival rate, SEER uses data from different areas throughout the country. To get the five-year survival rate, numbers must be analyzed over a range of time. This means that the patients included in the analysis received treatment and care that may be different from today. Knowledge and treatment have improved in recent years.
There are many other ways to look at survival. Besides the five-year survival rate, people also measure:
- Overall survival: the length of time from diagnosis to a patient’s death
- Progression-free survival: how long a person stays on a treatment without their disease getting worse
- Disease-free survival: the amount of time a person is believed to be cancer-free, also known as “no evidence of disease”
These other survival measurements are often used to judge success of clinical trials.
Why Is Early Detection Important?
Patients whose disease is diagnosed in its earlier stages have better outcomes. This is due to a greater likelihood that they are eligible for surgery.
The Pancreatic Cancer Action Network and others are working to find pancreatic cancer earlier through:
- Awareness of symptoms
- Studies focused on biomarkers (biological clues that can show signs of disease)
- Efforts to improve imaging techniques
- Efforts to improve the identification and monitoring of people at higher risk for the disease
We’re Here to Help
Contact PanCAN Patient Services for free pancreatic cancer resources, information and support, including information about the latest treatment options.
- American Cancer Society. Cancer Facts & Figures 2024. Atlanta: American Cancer Society; 2024 https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2024/2024-cancer-facts-and-figures-acs.pdf
- American Cancer Society, Cancer Facts and Figures 2015-2024.
- Blackford AL, Canto MI, Klein AP, Hruban RH, Goggins. J Natl Cancer Inst. Ann Surg Oncol. 2020 Nov 1;112(11):1162-1169.
Page last updated January 2024